Beth Israel Clinical Departments 2011 Year End Report
Total Page:16
File Type:pdf, Size:1020Kb
Beth Israel Clinical Departments 2011 Year End Report Beth Israel Clinical Departments Year End Report Table of Contents Department of Anesthesiology 1 Department of Dermatology 5 Department of Emergency Medicine 9 Department of Integrative Medicine 15 Department of Medicine 21 I. Division of Cardiology 23 II. Division of Chemical Dependency 28 III. Division of Clinical Immunology and Allergy 31 IV. Division of Digestive Diseases 32 V. Division of Endocrinology 35 VI. General Medical Associates 39 VII. Division of Geriatric Medicine 42 VIII. Hospital Medicine 45 IX. Division of Infectious Diseases 51 X. Division of Infectious Diseases—AIDS Center 59 XI. Internal Medicine Residency Training Program 62 XII. Methadone Maintenance Treatment Program (MMTP) 65 XIII. Division of Nephrology and Hypertension 71 XIV. Occupational Medicine/Employee Health And Business Health Services 74 XV. Division of Pulmonary and Critical Care 77 XVI. Division of Rheumatology 84 Department of Neurology 87 Department of Neurosurgery 103 Department of Obstetrics and Gynecology 107 Department of Orthopedic Surgery 113 Department of Otolaryngology 119 Department of Pain Medicine and Palliative Care 127 Department of Pathology and Laboratory Medicine 139 Department of Pediatrics 147 Department of Physical Medicine and Rehabilitation 159 Department of Psychiatry and Behavioral Sciences 167 Department of Radiology 181 Department of Surgery 189 Department of Urology 199 Continuum Cancer Centers of New York 205 Patient Care Services 217 Year End Activity Report/Faculty Listing 231 2011 Year End Report A3 Department of Anesthesiology 2011 Department of Anesthesiology DEPARTMENT OF ANESTHESIOLOGY Sundar Koppolu, MD, Chairman 1. New Faculty — Jesse Searles, MD, Assistant Physician, Full-time, August 2011. 2. Program Enhancements A. New Programs i. Anesthesia Services at Carnegie Endoscopy Center: Planning construction and implementation of Anesthesia Services at Carnegie Endoscopy Center. 3. Capital Enhancements A. Equipment Enhancements i. Updating the old anesthesia machines and monitors at the Petrie Division and Beth Israel Brooklyn. 4. Quality Initiatives/Achievements A. Perioperative Services with FOJP. B. Blood management at Petrie. C. Number of anesthetics administered: — Petrie - 32,372 — PACC - 7,817 — Kings Highway - 9,304 — Beth Israel Cancer Center – 1,450 — East Side Endoscopy Center – 9,553. 2011 Year End Report 3 Department of Dermatology 2011 Department of Dermatology DEPARTMENT OF DERMATOLOGY Vincent DeLeo, MD, Chairman 1. Program Enhancements A. New Programs i. Cutaneous Cancer Service at CCCNY: Relocated the Mohs service to the BI West Campus in January 2011. Residents also receive surgical training at this location. 2. Quality Initiatives/Achievements A. The department developed a dashboard to track our quality initiatives. 3. Fellow/Resident Board Passage Rates — Fellows: N/A. — Residents: 75%. 4. Peer-Reviewed Publications and Presentations A. Peer-Reviewed Publications — Rossi, Alexis. “Cosmetic Procedures in Skin of Color.” G Ital Dermatol Venereol. 2011 August 146 (4): 265-72. — Shah, Arthur, Yang, Stevens, Alexis. “A Retrospective Study to Investigate Racial and Ethnic Variations in the Treatment of Psoriasis with Etanercept.” J Drugs Dermatol. 2011 August 1 10 (8): 866-72. — Summers, Bena, Arrigain, Alexis, Cooper, Bordeaux. “Sunscreen Use: Non- Hispanic Blacks Compared with Other Racial and/or Ethnic Groups.” Arch Dermatol. 2011 July 147 (7): 863-4. — Alexis. “Acne in Patients with Skin of Color.” J Drugs Dermatol. 2011 June 1 10 (6): s 13-6. — Shah, Bhanusali, Sachdev, Geria, Alexis. “A Survey of Skin Conditions and Concerns in South Asian Americans: A Community-Based Study.” J Drugs Dermatol. 2011 May 10 (5): 524-8. — Coley, Bhanusali, Silverberg, Alexis, Silverberg. “Scalp Hyperkeratosis and Alopecia in Children of Color.” J Drugs Dermatol. 2011 May 10 (5): 511-6. — Alexis. “Skin of Color: Progress Made, Challenges Remain.” J Drugs Dermatol. 2011 May 10 (5): 459-60. — Weinberg, Koestenblatt. “Treatment of Interdigital Tinea Pedis: Once-Daily Therapy with Sertaconazole Nitrate.” J Drugs Dermatol. 2011 October 10 (10): 1135-40. — Weinberg. “Rights and Wrongs.” Cutis. 2011 September 88: 112-113. — Fung, Xi, Yang, Seiffert-Sinha, Wai Chie Lai, Sinha. “Quantitative Analysis of Human Keratinocyte Cell Elasticity Using Atomic Force Microscopy (AFM).” IEEE Transactions on NanoBioScience. 2011 March 10 (1): 9. — Sachdev, Bhanusali, Zamora, Gerlach, Sinha. “PTPN22 1858T Is Not a Risk Factor for North American Pemphigus Vulgaris.” Exp Dermatol. 2011 June 20 (6): 514. 2011 Year End Report 7 Department of Dermatology — Coda,Sinha.“IntegrationofGenome-WideTranscriptionalandGeneticProfiles Provides Insight into Disease Development and Clinical Heterogeneity in Alopecia Areata.” Genomics. 2011 September 98 (6): 431. — Chacon, Sinha. “Bullous Pemphigoid after Herpes Zoster Vaccine Administration: Association or Coincidence?” J Drugs Dermatol. 2011 November 10 (11): 1328. — Murrell, Daniel, Joly, Borradori, Amagai, Hashimoto, Caux, Marinovic, Sinha, Hertl, Bernard, Sirois, Cianchini, Fairley, Jonkman, Pandya, Rubenstein, Zillikens, Payne, Woodley, Zambruno, Aoki, Pincelli, Diaz, Hall, Meurer, Mascaro, Schmidt, Shimizu, Zone, Swerlick, Mimouni, Culton, Lipozencic, Bince, Bystryn,Werth.“DefinitionsandOutcomeMeasuresforBullousPemphigoid: Recommendations by an International Panel of Experts.” J Am Acad Dermatol. 2011 December 66 (3): 479. 5. Honors/Awards Vincent DeLeo, MD — New York Magazine’s Best Doctors. Rajiv Nijhawan, MD, Resident: — First Place, American Society of Dermatologic Surgery Resident Jeopardy Competition. — American Society of Dermatologic Surgery Scholarship Award. Anthony Rossi, MD, Resident: — First Place, American Society of Dermatologic Surgery Resident Jeopardy Competition. — American Society of Dermatologic Surgery Scholarship Award. Jonathan Silverberg, MD, Resident: — Travel Award for Federation of Clinical Immunology Societies 2011 Annual Meeting, Washington, DC. — Selected Participant for the Resident Retreat for Future Physician Scientists, Society of Investigative Dermatology, Phoenix, AZ. — Young Alumnus Award, City University of New York, Brooklyn College. 2011 Year End Report 8 Department of Emergency Medicine 2011 DepartmentEmergency Medicine of Emergency Medicine THE DAVID B. KRISER DEPARTMENT OF EMERGENCY MEDICINE Gregg Husk, MD, Chairman 1. Program Enhancements A. New Programs i. Patient Satisfaction: We implemented a patient satisfaction survey for the ED, and are using it as the centerpiece of staff and management meetings. We have imple- mented “internal benchmarking” in our patient satisfaction program. ii. Operational Efficiency in Our Non-Teaching Zone: We have implemented a scribe programtoimprovethetime-efficiencyofcare,andclinicaldocumentation. iii. Improvement of ED Professional Revenue by a Clinical Documentation Improvement Program: Dr. Joseph Habboushe, an MD/MBA member of our faculty, is coaching residents, physician assistants and attending physicians on improving documenta- tion, resulting in improved professional collections. iv. Care of Sepsis Patients: We have worked with colleagues from Critical Care to sim- plifythesepsisprogram,andmodifiedourelectronichealthrecordtobettercapture clinical process quality indicators. 2. Capital Enhancements A. Equipment Enhancements i. We upgraded the monitoring equipment at Beth Israel Brooklyn, resulting in improved capability to monitor patients and to document the patients’ physiology. 3. Quality Initiatives/Achievements A. In 2011, the ED was strongly focused on managing the increase in patient volume associ- ated with the 4/2010 closure of St. Vincent’s. We focused on improving the total treat- ment time for patients in our non-teaching zone, reducing walkout rates, and beginning to measure and manage patient satisfaction. Walkout rates rose in 2011, but we were able to improveoperationalefficiency,andpatientexperienceisbeginningtoimprove. i. We hoped to improve overall treatment time for patients in the “Orange” (non-teach- ing) pod of the ED by 15% (compared to the 2010 TAT in the main ED). We exceeded our goals. The 2010 treatment time in the ED for 2010 (excluding pedi- atrics) was 4.1 hours. For the Orange pod in 2011, the overall treatment time was 3.2 hours, 22% less than the historical average for the main ED. This environment is a non-teaching environment, staffed by ED attendings and PAs. There are no ED residents, or residents from other services who rotate through the area. We anticipated that reducing the “overhead” of educational activities would improve cycle times, and our results are consistent with this. Wecenteredon“Orangepod”efficiencyinourdepartmentalmanagementmeetings for 2011, and made a number of changes to evaluate means by which the Orange podcancontributetooveralldepartmentalefficiency(notonlyfocusingonTATfor patients within Orange, but also case-mix of the patients within Orange, utilization of Orange pod spaces during the early morning hours, and focusing the Scribe program 2011 Year End Report 11 DepartmentEmergency Medicine of Emergency Medicine within Orange). Overall, the percentage of ED volume cared for in Orange during its hours of operation rose by about 4% during 2011. ii. Managing patient walkout rates when ED volumes increase. The ED volume at Petrie has increased by 23% since the closure of St. Vincent’s Catholic Medical Center, and the ED completed its renovation and move into a new clinical space. In association